continue to occur. Since corticosteroids possess anti-inflammatory and anti-fibrotic effects, we 23 tested the ability of dexamethasone to inhibit inflammation and prevent oviduct scarring in mice curve generated using a 16s rRNA-amplified PCR product of known concentration and adjusted euthanized on day 42 to evaluate chronic oviduct pathology.
130
In an adjunctive steroid treatment protocol (Fig. 1, experiment 4 
RESULTS

177
Histopathology of oviducts harvested on day 21 of infection reveals preservation of 178 the oviduct structure with steroid treatment. In our initial experiment (Fig. 1, experiment 1 were euthanized at day 21 of infection, and their oviducts were harvested for histopathology.
181
Microscopic examination revealed relative preservation of the oviduct structure in mice 182 receiving 1 mg/kg/day of dexamethasone (Fig. 2B ) or 2.5 mg/kg/day of dexamethasone (Fig. 2C ) 183 compared to a control group receiving PBS ( Fig. 2A) influx of inflammatory cells into the oviduct and a subsequent reduction in chronic pathology.
Oviducts were harvested from steroid-treated C57BL/6 and C3H/HeOuJ mice on day 11 or 14 of 191 infection, respectively (Fig. 1, experiments 2 and 3 ). These are days we have noted that 192 neutrophil numbers peak in the oviducts of the respective mouse strains after C. muridarum 193 infection 9,39 . We detected a 6-fold reduction in the numbers of neutrophils (Fig. 3A) and a non-194 statistically significant reduction in the numbers of macrophages (Fig. 3B ) in the oviducts of
195
C3H/HeOuJ mice treated with 1 or 2.5 mg/kg of dexamethasone compared to infected controls.
196
Steroid treatment also resulted in a decrease in the numbers of CD4 + (Fig. 3C ) and CD8 + T cells (Fig 4) , an 233 increase in lower genital tract bacterial burden was observed during the time of high-dose steroid 234 treatment ( Fig 1A, supplemental data) .
235
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These findings led to a further refinement of our experimental treatment protocol to a 236 shortened, 3-day burst of dexamethasone on days 11-13 (C57BL/6) or 14-16 of infection
237
(C3H/HeOuJ) in combination with doxycycline for 5 days (Fig. 1 , experiments 5 and 6 and 238 Table 1 ). Treatment days were chosen based on our prior determination of peak days of oviduct 239 neutrophil influx in C57BL/6 39 and C3H/HeOuJ mice 9 . Although no increase in bacterial burden 240 was observed during short-course steroid treatment and a rapid resolution of infection occurred 241 with doxycycline therapy (Fig. 1B, supplemental data) , no improvement in oviduct dilatation 242 scores were observed on day 42 post infection (Table 1 , experiments 5 and 6). All groups that 243 received doxycycline alone exhibited lower dilatation scores compared to control groups given
244
PBS and those given dexamethasone together with doxycycline, but these differences were not 245 statistically significant (Table 1) .
246
DISCUSSION
247
An overly robust host inflammatory response to Chlamydia causes damage to the delicate 248 structures of the oviduct 5,42 . Steroids given alone or as an adjunct to antibiotics are potent anti-249 inflammatory agents that have been shown to reduce pathology and improve outcomes in a 250 variety of inflammatory disorders 21, 26, 27, 29, 31, 43 . Therefore, we sought to determine whether the 251 administration of steroids to mice with chlamydial genital tract infection would decrease oviduct 252 inflammation and reduce chronic oviduct pathology.
253
We determined that although dexamethasone administered in doses of 1 and 2.5 mg/kg 254 per day led to a statistically significant decrease in the number of neutrophils infiltrating the 255 oviducts during a time of peak inflammation, subsequent pathologic evaluation of tissues from 256 mice treated similarly revealed no reduction in chronic oviduct damage compared to controls. with doxycycline treatment also failed to improve outcomes. 
